Developers: | XVIVO Perfusion |
Branches: | Pharmaceutics, medicine, health care |
2016: Clinical trials
In May, 2016 it became known of testing of the device for storage of donor easy XPS. The innovation developed by the Swedish company XVIVO Perfusion gives hope for rescue of many people with chronic diseases of respiratory organs.
XPS represents the special camera in which lungs of the donor are pumped up by the oxygen, proteins and different medicines and nutrients necessary for maintenance of normal life activity of the body preparing for transplantation. In this equipment the conditions similar to in what lungs are in a human body are recreated.
On May 17, 2016 the Reuters news agency reported that XPS passes clinical trials in 16 American medical centers, including at the University of Washington, Duke University and Presbyterian hospital of New York.
By May, 2016 the device is approved for use in medical institutions of Europe and Canada. In the USA XPS passes clinical trials, and to some patients successfully replaced lungs which were stored in this camera. Among them — the former smoker 63-year-old Michele Coleman who had an incurable chronic obstructive pulmonary disease.
Out of a body, without blood and oxygen, cells of lungs collapse very quickly. Because of the vulnerability lungs often are not suitable for transplantation. Statistics shows that less than 20% of lungs are suitable for transplantation, and approximately every fourth patient expecting change dies.
XPS is capable to solve these problems due to increase in number of suitable donor organs. However, even this transaction does not guarantee long life: a half of people to whom replaced lungs lives only five years.[1]